1
0
0
News
Taz: Warten auf die Heuschrecken - taz.de
Frank und Dagmar Dieterich gehen betteln um Betten. Rund Menschen sollen zum 27. Evangelischen Kirchentag in Leipzig kommen ■ Von Alexander Friebel
Vierte "Church Night" in Eilshausen - nw.de
www.nw.de
Anders als gewohnt hat sich wieder einmal die Eilshauser Kirche präsentiert. Zum vierten Mal erstrahlte das Gebäude, ganz im Zeichen des Reformationsfestes...
NexImmune Appoints Kenneth Carter, PhD, as President and CEO and...
www.firmenpresse.de
Licenses Technology From The Johns Hopkins University ...
NEWSTRACK India
www.newstrackindia.com
Washington, Dec 1 (ANI): In a new study, researchers at Johns Hopkins have ... activation," said immunologist and study senior investigator Mathias Oelke, Ph.D. ...
Netzwerk-Profile
LinkedIn: Mathias Oelke – Adjunct Assistent Professor – Johns Hopkins...
Mitglied von LinkedIn werden Zusammenfassung. Accomplished Ph.D. scientist and business partner with 20 years experience in cancer immunotherapy and deep expertise in
LinkedIn: Mathias Oelke – Adjunct Assistent Professor - pl.linkedin.com
Wyświetl pełny profil użytkownika Mathias Oelke. Bezpłatnie! Na LinkedIn znajdziesz kolegów z pracy, uczelni i 500 milionów innych specjalistów.
Interessen
Mathias Oelke - Patents
www.freshpatents.com
Recent bibliographic sampling of Mathias Oelke patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):
202 In vivo and in vitro characterization of AIM ACT, a novel ...
jitc.bmj.com
von R Wang · — Ruipeng Wang, · Lauren Suarez, · Emily Lu, · Pratima Kunwar, · Daniel Dembrow, · Sojung Kim and · Mathias Oelke. › Suppl_2
new strategies to improve immunotherapy of cancer
www.cell.com
von C Krueger · · Zitiert von: 3 — Christine Krueger, Jonathan P. Schneck and Mathias Oelke. Department of Pathology & Medicine, The Johns Hopkins School of Medicine, Baltimore, ... › trends › molecular-medicine › pdf
Business-Profile
Mathias OELKE | SVP, Head of Pre-Clinical Immunotherapy ...
www.researchgate.net
› profile › Mathias-Oelke
Private Homepages
Page125
mitglied.multimania.de
... mathewsinc · mathey tissot · mathias dapfner · mathias furrow · mathias lauridsen · mathias oelke · mathias reim verdammt ich lieb dich · mathias reim wie man ...
Besitz
Reagents and methods for identifying ...
patentscope.wipo.int
Mathias Oelke. Title: Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cells. Abstract: Antigen-specific T cells, including ...
Bücher
Andrew Kin - EHA Library - European Hematology Association
library.ehaweb.org
Mathias Oelke. ,. Mathias Oelke. Affiliations: Pre-clinical Research,Neximmune, Inc,Gaithersburg, MD,United Kingdom. Daniel Bednarik. ,. Daniel Bednarik. › eha › a...
fachbuchquelle.de Weinbrenner Buch-Shop
www.drw-verlag.de
Reeg, Tatjana / Brix, Mathias / Oelke, Manuel / Konold, Werner Baumlandschaften Nutzen und Ästhetik von Bäumen in der offenen Landschaft Bäume kommen ...
PLOS Neglected Tropical Diseases: T-Cell Memory Responses Elicited by...
journals.plos.org
Author Summary T-cell responses are considered to be very important; however, the role of T-cell responses in vaccine mediated immunity is still controversial....
AACR Proceedings: Abstracts
books.google.com
Sojung Kim, Lauren Suarez, Emily Lu, Celine Walmacq, Daniel Dembrow, Juan Varela, Dan Bednárik, Kenneth Carter, Naimish Pandya, Kristi Jones, Mathias Oelke.
Dokumente zum Namen
Enrichment and Expansion with Nanoscale Artificial Antigen ...
pubs.acs.org
von K Perica · · Zitiert von: 119 — ... Han Myint, Kristi Jones, Mathias Oelke. AIM Platform: A Novel Nano Artificial Antigen-Presenting Cell-Based Clinical System Designed to ... › doi › abs
Artificial Antigen-Presenting Cells for Use in Adaptive Immunother.....
www.authorstream.com
Artificial Antigen-Presenting Cells for Use in Adaptive Immunother..- authorSTREAM Presentation
Evaluation of Topoisomerase-1–Specific CD8 - T-Cell ...
nyaspubs.onlinelibrary.wiley.com
von F BOIN · · Zitiert von: 18 — MATHIAS OELKE,b AND ANTONY ROSENa. aDivision of Rheumatology, Department of Medicine, Johns Hopkins School of Medicine,. Baltimore, Maryland , USA. › annals
Development of Antigen Presenting Cells for Adoptive Immunotherapy ...
www.dtic.mil
PRINCIPAL INVESTIGATOR: Mathias Oelke, Ph.D. CONTRACTING ORGANIZATION: Johns Hopkins University. Baltimore, MD
Wissenschaftliche Veröffentlichungen
Heat shock protein 70/peptide complexes: potent mediators for the...
translational-medicine.biomedcentral.com
Sabine Tischer, Megan Basila, Britta Maecker-Kolhoff, Stephan Immenschuh, Mathias Oelke, Rainer Blasczyk and Britta Eiz-Vesper*.
Key found to restoring 'exhausted' HIV-fighting immune cells
www.sciencedaily.com
Researchers have identified a protein that causes loss of function in immune cells combating HIV. The scientists report that the protein, Sprouty-2, is a...
Decline of influenza-specific CD8+ T cell repertoire in healthy...
immunityageing.biomedcentral.com
While influenza vaccination results in protective antibodies against primary infections, clearance of infection is primarily mediated through CD8+ T cells....
Magnetic nanoparticles could be key to effective immunotherapy: New...
www.sciencedaily.com
In recent years, researchers have hotly pursued immunotherapy, a promising form of treatment that relies on harnessing and training the body's own immune...
Veröffentlichungen allgemein
Decline of influenza-specific CD8 + T cell repertoire in healthy...
link.springer.com
Background While influenza vaccination results in protective antibodies against primary infections, clearance of infection is primarily mediated through CD8+ T...
Oalib search
www.oalib.com
Jessica B Lee, Mathias Oelke, Lakshmi Ramachandra, David H Canaday, Jonathan P Schneck Immunity & Ageing , 2011
Artikel & Meinungen
Twitter-Nachrichten: Recherche Kollektiv Ostwestfalen a Twitter: "1. In #Herford lief ...
In #Herford lief bei den #AntiCorona-Demos ein Oberarzt des Klinikums Herford Mathias Oelke mit ( am Fronttranspi in gestreiftem Shirt) und bezeichnete die ... › recherchekolle1 › status
Ex vivo induction and expansion of antigen-specific cytotoxic T cells...
www.nature.com
On the Market
Sonstiges
Mathias Oelke | LinkedIn
www.linkedin.com
View Mathias Oelke's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Mathias Oelke discover inside ...
Mathias Oelke | VP, Head of Pre-Clinical and Platform LinkedIn
www.linkedin.com
Check out professional insights posted by Mathias Oelke, VP, Head of Pre- Clinical and Platform Development at NexImmune.
EP A4 - Auf immunhemmern basierende diagnose- und...
patents.google.com
Mathias Oelke, Jonathan Schneck, Tonya Webb: Antragsteller: Univ Johns Hopkins: Zitat exportieren: BiBTeX, EndNote, RefMan: Patentzitate (1), Nichtpatentzitate (4 ...
Novel Approach to Adoptive Immunotherapy Developed by ...
finance.yahoo.com
Dr. Mathias Oelke, Scientific Co-founder and Senior Director of Discovery at NexImmune and co-author on the publication, noted the broad ...
Mathias Oelke - Academia.edu
independent.academia.edu
Academia.edu is a place to share and follow research.
NexImmune promotes insider Mathias Oelke to Flipboard
flipboard.com
› article › https: › flipboard.com
Immunotherapy with Enhanced Self Immune Cells - Mathias ...www.discoverymedicine.com › › immun...
www.discoverymedicine.com
Published on June 20, Author: Mathias Oelke. Institution: Departments of Pathology & Medicine, The Johns Hopkins University School of Medicine
AME » Blog Archive » Rambam Maimonides Medical Journal
moked.it
Cancer Immunotherapy Adoptive T Cell Immunotherapy For Cancer Karlo Perica, Juan Carlos Varela, Mathias Oelke, and Jonathan Schneck.
Enrichment and Expansion with Nanoscale Artificial Antigen Presenting...
figshare.com
Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy
Our Team – Schneck Laboratory
labs.pathology.jhu.edu
Mathias Oelke, Ph.D. – NexImmune. Past Undergraduate Students. Kevin Necochea – Johns Hopkins University. Leah Sibener – 3T Biosciences. Andy Tu – MIT. Fernando Vicente – Johns Hopkins University : A SiteOrigin Theme
HLA-Ig-based artificial antigen-presenting cells: Setting the terms...
jhu.pure.elsevier.com
HLA-Ig-based artificial antigen-presenting cells: Setting the terms of engagement. Mathias Oelke, Jonathan P Schneck · School of Medicine. Research output: ...
AIM Platform: A Novel Nano Artificial Antigen-Presenting Cell ...
www.karger.com
von L Suarez · · Zitiert von: 1 — Mathias Oelke. PreClinical Immunotherapy, NexImmune, Inc Gaither Road. Gaithersburg, MD (USA) › FullText
Artificial antigen-presenting cells: Artificial solutions for real...
jhu.pure.elsevier.com
Artificial antigen-presenting cells: Artificial solutions for real diseases. Mathias Oelke, Christine Krueger, Robert L. Giuntoli, Jonathan P. Schneck · School of Medicine. Research output: Contribution to journal › Article ...
Artificial antigen-presenting cells - PubMed
pubmed.ncbi.nlm.nih.gov
von M Oelke · · Zitiert von: 56 — Authors. Mathias Oelke , Christine Krueger, Robert L Giuntoli 2nd, Jonathan P Schneck. Affiliation. 1 Department of Pathology and Medicine, ... › ...
Bibliographic Data - Application - Patent Center - USPTO
patentcenter.uspto.gov
Mathias Oelke. Baltimore, MARYLAND (US). Applicants. Data not available. Examiner. MARIANNE DIBRINO. Resources & Contact. Resources.
Wiley-VCH - Human Immunology
www.wiley-vch.de
Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim - A passion for publishing
Development of an Artificial-Antigen-Presenting-Cell-Based ...
journals.asm.org
von ZM Ndhlovu · · Zitiert von: 14 — Authors: Zaza M. Ndhlovu, Monika Angenendt, Diana Heckel, Jonathan P. Schneck, Diane E. Griffin, Mathias Oelke [email protected]Authors Info & Affiliations. › doi › abs
NexImmune Acquired by a Consortium of Private Investors Led by Former...
drug-dev.com
NexImmune's AIM technology, originally developed by Dr. Jonathan Schneck and Dr. Mathias Oelke at the Johns Hopkins School of Medicine, was licensed ...
sortiert nach Relevanz / Datum